Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $16.25

Pediatrix Medical Group, Inc. (NYSE:MD) has been assigned a consensus rating of “Hold” from the six analysts that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $16.25.

MD has been the topic of several recent research reports. Mizuho upped their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Truist Financial reduced their target price on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating on the stock in a report on Monday, January 6th. Jefferies Financial Group boosted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Macquarie initiated coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th.

Insider Buying and Selling

In other Pediatrix Medical Group news, Director Mark S. Ordan sold 27,600 shares of the business’s stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the sale, the director now directly owns 138,683 shares of the company’s stock, valued at $2,128,784.05. The trade was a 16.60 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Mary Ann E. Moore sold 8,108 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total transaction of $129,728.00. Following the completion of the sale, the executive vice president now directly owns 135,810 shares of the company’s stock, valued at approximately $2,172,960. This trade represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds have recently modified their holdings of the business. Quest Partners LLC raised its stake in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares in the last quarter. Quarry LP raised its stake in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after acquiring an additional 1,662 shares in the last quarter. CWM LLC raised its stake in shares of Pediatrix Medical Group by 134.0% during the 3rd quarter. CWM LLC now owns 6,427 shares of the company’s stock worth $74,000 after acquiring an additional 3,681 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in Pediatrix Medical Group during the 2nd quarter valued at approximately $72,000. Finally, FMR LLC increased its stake in Pediatrix Medical Group by 220.6% during the 3rd quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after purchasing an additional 6,771 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $14.22 on Friday. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of -4.65, a PEG ratio of 1.42 and a beta of 1.58. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. The stock’s 50-day simple moving average is $13.99 and its 200-day simple moving average is $12.22. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $16.41.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The firm had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. Pediatrix Medical Group’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.29 earnings per share. As a group, analysts expect that Pediatrix Medical Group will post 1.26 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.